This technology is an ensemble of modified erastin analogs generated with higher potency, solubility, and stability for pro-ferroptotic activity for tumor cells harboring varying oncogenic RASV12 mutations.
This technology is a versatile biomaterial platform composed of alginate and polyol-based fibers designed for sustainable textile manufacturing through knitting, printing, and casting techniques.
